| HGNC Family | Non-coding RNAs |
| Name | microRNA 744 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR‑744 has emerged as a multifunctional regulator in a variety of cancers, exhibiting context‐dependent roles that can be either oncogenic or tumor suppressive. In pancreatic and prostate cancers, its upregulation potentiates oncogenic signalling—by activating the Wnt/β‑catenin pathway through direct targeting of negative regulators such as secreted frizzled‑related protein 1, glycogen synthase kinase‑3β and transducin‑like enhancer of split—as well as promoting metastasis via modulation of transcription factors like c‑FOS. In nasopharyngeal and head and neck carcinomas, elevated miR‑744 levels are associated with enhanced migration and invasion through transcriptional regulation of pro‑tumorigenic genes (e.g. ARHGAP5 and MMP‑9). Conversely, in other tumour types such as epithelial ovarian, papillary thyroid and certain colorectal cancers, enforced expression of miR‑744–5p restricts cell proliferation and induces apoptosis by targeting key oncogenic mediators including Bcl‑2, c‑myc and ARF1. Moreover, in osteosarcoma, aberrant miR‑744 expression promotes proliferation via the PTEN/AKT pathway, while in a subset of colorectal tumours it contributes to chemoresistance by suppressing BIN1."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its direct effects on tumour cell behaviour, miR‑744–5p is subject to intricate regulation by various non‑protein‐coding RNAs that function as competing endogenous RNAs. In lung adenocarcinoma, the oncogenic long non‑coding RNA MAFG‑AS1 acts as a molecular sponge for miR‑744–5p, thereby relieving repression of nearby transcription factors. Similar competitive interactions have been described in glioma and pituitary adenoma, where lncRNA LINC01116 sequesters miR‑744–5p to preserve the expression of oncogenic targets such as MDM2 and HOXB8. Furthermore, in colorectal and ovarian cancers, deregulated lncRNAs like MNX1‑AS1 contribute to malignant progression by competitively binding miR‑744–5p, a process that is reinforced by the delivery of miR‑744–5p via mesenchymal stem cell‑derived extracellular vesicles."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its cell‐intrinsic effects in cancer, miR‑744 plays pivotal roles as a biomarker and modulator of non‑malignant pathophysiological processes. Its altered expression in circulating exosomes has been linked to hepatocellular carcinoma progression and chemoresistance, while downregulation in cardiac fibroblasts alleviates angiotensin II–induced collagen deposition and fibrogenesis through direct targeting of transforming growth factor‑β1. In renal mesangial cells, miR‑744 enhances type I interferon signalling by repressing negative phosphatases, and in psoriasis it not only promotes keratinocyte proliferation but also delays differentiation via inhibition of targets such as KLLN. Moreover, miR‑744–5p has shown promise as a biodosimeter for radiation exposure, and its progressive upregulation during T cell activation suggests an important role in modulating T cell differentiation and functionality through targeting regulators like STK11."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yuan Fang, Xiaoxia Zhu, Jian Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.3754"}], "href": "https://doi.org/10.18632/oncotarget.3754"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25961434"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25961434"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Wei Zhou, Yongfeng Li, Shanmiao Gou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.5317"}], "href": "https://doi.org/10.18632/oncotarget.5317"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26485754"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26485754"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xiao-Fang Chen, Yun Liu "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-744 inhibited cervical cancer growth and progression through apoptosis induction by regulating Bcl-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2016.04.023"}], "href": "https://doi.org/10.1016/j.biopha.2016.04.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27261616"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27261616"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "John Zeng-Hong Li, Wei Gao, Wen-Bin Lei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.11280"}], "href": "https://doi.org/10.18632/oncotarget.11280"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27533461"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27533461"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Zhou Sha, Xiaoxia Zhu, Na Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.11285"}], "href": "https://doi.org/10.18632/oncotarget.11285"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27533465"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27533465"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Han Guan, Chunhui Liu, Fang Fang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.14711"}], "href": "https://doi.org/10.18632/oncotarget.14711"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28107193"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28107193"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Sara Y Kim, Tsutomu Kawaguchi, Li Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Surg Oncol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1245/s10434-017-5984-2"}], "href": "https://doi.org/10.1245/s10434-017-5984-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28766230"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28766230"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Michael Kleemann, Helga Schneider, Kristian Unger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-27438-6"}], "href": "https://doi.org/10.1038/s41598-018-27438-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29899543"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29899543"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Y Zhou, A He, L Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-744 mediates the Oxaliplatin chemoresistance in colorectal cancer through inhibiting BIN1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasma (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4149/neo_2019_190508N411"}], "href": "https://doi.org/10.4149/neo_2019_190508N411"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31884801"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31884801"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Wei Yu, Peng-Bo Chen, Fan-Cheng Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-744 promotes proliferation of osteosarcoma cells by targeting PTEN."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2020.11030"}], "href": "https://doi.org/10.3892/mmr.2020.11030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32186762"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32186762"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Qingling Yuan, Yuxia Fan, Zheng Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-744-5p mediates lncRNA HOTTIP to regulate the proliferation and apoptosis of papillary thyroid carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2020.112024"}], "href": "https://doi.org/10.1016/j.yexcr.2020.112024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32335029"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32335029"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Lai-Gang Zhao, Jiao Wang, Jin Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-744-5p inhibits cellular proliferation and invasion via targeting ARF1 in epithelial ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Kaohsiung J Med Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/kjm2.12253"}], "href": "https://doi.org/10.1002/kjm2.12253"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32558345"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32558345"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Wei Zhang, Kai Liao, Dongning Liu "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA‑744‑5p is downregulated in colorectal cancer and targets SEPT2 to suppress the malignant phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2020.11692"}], "href": "https://doi.org/10.3892/mmr.2020.11692"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33200802"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33200802"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Shangbiao Li, Simiao Qiao, Na Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-744 Functions as an Oncogene Through Direct Binding to c-Fos Promoter and Facilitates Non-small Cell Lung Cancer Progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Surg Oncol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1245/s10434-021-10688-6"}], "href": "https://doi.org/10.1245/s10434-021-10688-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34599436"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34599436"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yuan Sui, Guangyao Lin, Yinshi Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Pharmacol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejphar.2019.172465"}], "href": "https://doi.org/10.1016/j.ejphar.2019.172465"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31211984"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31211984"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Liming Gao, Qi Tian, Tong Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduction of miR-744 delivered by NSCLC cell-derived extracellular vesicles upregulates SUV39H1 to promote NSCLC progression via activation of the Smad9/BMP9 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12967-020-02654-9"}], "href": "https://doi.org/10.1186/s12967-020-02654-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33472665"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33472665"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Shiping Huang, Yueming Sun "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA MNX1-AS1 functions as a competing endogenous RNA to regulate epithelial-mesenchymal transition by sponging MiR-744-5p in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Biotechnol Biochem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/bbb/zbaa096"}], "href": "https://doi.org/10.1093/bbb/zbaa096"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33590038"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33590038"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Farah Hady El Kilany, Rana Ahmed Youness, Reem Amr Assal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-744/eNOS/NO axis: A novel target to halt triple negative breast cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/BD-200454"}], "href": "https://doi.org/10.3233/BD-200454"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33749631"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33749631"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Li Jiang, Chao Cheng, Wei Ji, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC01116 promotes the proliferation and invasion of glioma by regulating the microRNA‑744‑5p‑MDM2‑p53 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2021.12005"}], "href": "https://doi.org/10.3892/mmr.2021.12005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33760190"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33760190"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Tengchao Huang, Meiqin Cai, Chuan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC01116 boosts the progression of pituitary adenoma via regulating miR-744-5p/HOXB8 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Endocrinol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mce.2021.111350"}], "href": "https://doi.org/10.1016/j.mce.2021.111350"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34098015"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34098015"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Yang Shen, Mengmeng Lv, Yichen Fang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Ovarian Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13048-021-00910-0"}], "href": "https://doi.org/10.1186/s13048-021-00910-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34789303"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34789303"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Ling Liu, Meixiong Cheng, Tian Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mesenchymal stem cell-derived extracellular vesicles prevent glioma by blocking M2 polarization of macrophages through a miR-744-5p/TGFB1-dependent mechanism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Toxicol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10565-021-09652-7"}], "href": "https://doi.org/10.1007/s10565-021-09652-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34978010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34978010"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Xiaoyan Zhang, Xiao Han, Yuanjia Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-744 enhances type I interferon signaling pathway by targeting PTP1B in primary human renal mesangial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep12987"}], "href": "https://doi.org/10.1038/srep12987"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26259828"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26259828"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Mahito Miyamae, Shuhei Komatsu, Daisuke Ichikawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2015.366"}], "href": "https://doi.org/10.1038/bjc.2015.366"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26505678"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26505678"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Lu Wang, Jiao Liu, Bin Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced exosome miR-425 and miR-744 in the plasma represents the progression of fibrosis and heart failure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Kaohsiung J Med Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.kjms.2018.05.008"}], "href": "https://doi.org/10.1016/j.kjms.2018.05.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30392569"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30392569"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Changyuan Wang, Jinbao Zong, Yongxi Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-744-3p regulates keratinocyte proliferation and differentiation via targeting KLLN in psoriasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Dermatol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/exd.13888"}], "href": "https://doi.org/10.1111/exd.13888"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30664260"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30664260"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Guanghui Wang, Wei Zhao, Huxia Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Sci Monit (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.12659/MSM.919219"}], "href": "https://doi.org/10.12659/MSM.919219"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31553714"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31553714"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Qistina Pilson, Siobhan Smith, Caroline A Jefferies, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-744-5p contributes to ocular inflammation in patients with primary Sjogrens Syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-020-64422-5"}], "href": "https://doi.org/10.1038/s41598-020-64422-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32366870"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32366870"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Michal Marczyk, Joanna Polańska, Andrzej Wojcik, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of the Applicability of microRNAs in Peripheral Blood Leukocytes as Biomarkers of Sensitivity and Exposure to Fractionated Radiotherapy towards Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms22168705"}], "href": "https://doi.org/10.3390/ijms22168705"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34445424"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34445424"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Jiayi Han, Jianqing Huang, Jieming Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-744-5p promotes T-cell differentiation via inhibiting STK11."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2024.148635"}], "href": "https://doi.org/10.1016/j.gene.2024.148635"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38830518"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38830518"}]}]}]}
|
| Synonyms | HSA-MIR-744, MIR-744, MIRN744 |
| NCBI Gene ID | 100126313 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR744 has 271 functional associations with biological entities spanning 5 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 15 datasets.
Click the + buttons to view associations for MIR744 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR744 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR744 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR744 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR744 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR744 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR744 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR744 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR744 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing MIR744 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR744 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MIR744 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR744 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR744 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR744 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR744 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |